[1] |
陈灏珠, 林果为, 王吉耀, 等. 实用内科学[M]. 14版. 北京: 人民卫生出版社, 2013: 182
|
|
Chen H Z, Lin G W, Wang J Y, et al. Practice of Internal Medicine [M]. 14th ed. Beijing: People's Medical Publishing House of China, 2013: 182.
|
[2] |
Blázquez-Prieto J, López-Alonso I, Huidobro C. The emerging role of neutrophils in repair after acute lung injury[J]. Am J Respir Cell Mol Biol, 2018, 59(3):289-294.
doi: 10.1165/rcmb.2018-0101PS
|
[3] |
Herrero R, Sanchez G. New insights into the mechanisms of pulmonary edema in acute lung injury[J]. Ann Translat Med, 2018, 6(2):32.
doi: 10.21037/atm
|
[4] |
Grailer J J, Canning B A, Kalbitz M, et al. Critical role for the NLRP3 inflammasome during acute lung injury[J]. J Immunol, 2014, 192(12):5974-5983.
doi: 10.4049/jimmunol.1400368
|
[5] |
Domej W, Foldes-Papp Z, Flogel E, et al. Chronic obstructive pulmonary disease and oxidative stress[J]. Curr Pharm Biotechnol, 2006, 7(2):117-123.
doi: 10.2174/138920106776597676
|
[6] |
dos Santos C C. The role of the inflammasome in ventilator-induced lung injury[J]. Am J Respir Crit Care Med, 2012, 185(11):1141-1144.
doi: 10.1164/rccm.201204-0649ED
|
[7] |
Martinon F, Mayor A, Petrilli V, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome[J]. Nature, 2006, 440(7081):237-241.
pmid: 16407889
|
[8] |
Yang H H, Duan J X, Liu S K, et al. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation[J]. Theranostics, 2020, 10(11):4749-4761.
doi: 10.7150/thno.43108
|
[9] |
Cao F, Tian X, Li Z, et al. Suppression of NLRP3 inflammasome by erythropoietin via the EPOR/JAK2/STAT3 pathway contributes to attenuation of acute lung injury in mice[J]. Front Pharmacol, 2020, 11:306.
doi: 10.3389/fphar.2020.00306
|
[10] |
Ruan H, Li W, Wang J, et al. Propofol alleviates ventilator-induced lung injury through regulating the Nrf2/NLRP3 signaling pathway[J]. Exp Mol Pathol, 2020, 114:104427.
doi: 10.1016/j.yexmp.2020.104427
|
[11] |
Dinarello C A, van der Meer J W. Treating inflammation by blocking interleukin-1 in humans[J]. Seminars Immunol, 2013, 25(6):469-484.
doi: 10.1016/j.smim.2013.10.008
|
[12] |
刘忠. 超短波联合动态干扰电治疗肩周炎患者的疗效分析[J]. 泰山医学院学报, 2018, 39(12):1382-1384.
|
|
Liu Z. The curative effect of ultrashort wave combined with dynamic interferometry in the treatment of shoulder periarthritis[J]. J Taishan Med Colleg, 2018, 39(12):1382-1384.
|
[13] |
王玉舫. 腹针加超短波电疗结合中药治疗慢性盆腔炎的临床护理效果观察[J]. 中国现代医生, 2017, 55(21):136-138.
|
|
Wang Y F. Observation on the clinical nursing effect of abdominal acupuncture plus ultrashort wave electrotherapy combined with traditional Chinese medicine in the treatment of chronic pelvic inflammation[J]. Chin Modern Doctor, 2017, 55(21):136-138.
|
[14] |
刘瑞, 陈娟, 张艳宁, 等. 关节腔注射联合超短波在骨关节炎患者中的应用效果[J]. 中国医药导报, 2019, 16(33):74-77.
|
|
Liu R, Chen J, Zhang Y N, et al. Application effect of intra-articular injection combined with ultrashort wave in patients with osteoarthritis[J]. Chin Med Herald, 2019, 16(33):74-77.
|
[15] |
苏浩, 杜姝, 陈丹莹, 等. 早期跑台训练联合超短波治疗对脊髓损伤大鼠功能恢复的影响[J]. 中华物理医学与康复杂志, 2019, 41(10):721-726.
|
|
Su H, Du S, Chen D Y, et al. The effects of early treadmill training combined with ultrashort wave irradiation on functional recovery from spinal cord injury[J]. Chin J Phys Med Rehabil, 2019, 41(10):721-726.
|
[16] |
白碧瑶, 吴曙粤. 肺部超短波治疗在小儿支气管肺炎恢复期的疗效探讨[J]. 中华物理医学与康复杂志, 2004, 26(2):128.
|
|
Bai B Y, Wu S Y. Effect of lung ultrashort wave therapy on convalescence of children with bronchopneumonosis[J]. Chin J Phys Med Rehabil, 2004, 26(2):128.
|
[17] |
顾新, 李艳, 李笑菊, 等. 超短波治疗老年肺炎[J]. 现代康复, 2000, 4(2):214-215.
|
|
Gu X, Li Y, Li X J, et al. The effect of ultra-short wave on senile pneumonia[J]. Modern Rehabil, 2000, 4(2):214-215.
|
[18] |
毛晶. 超短波辅助降阶梯疗法对老年重症肺炎的影响[J]. 安徽医学, 2015, 36(10):1241-1243.
|
|
Mao J. Effect of ultrashort wave assisted step-down therapy on severe pneumonia in the elderly[J]. Anhui Med J, 2015, 36(10):1241-1243.
|
[19] |
何予工, 阮翘, 常学民. 超短波对支气管肺炎患儿的疗效及其对细胞因子的影响[J]. 中华物理医学与康复杂志, 2006, 28(5):323-324.
|
|
He Y G, Ruan Q, Chang X M. Efficacy of ultrashort wave on children with bronchial pneumonia and its effect on cytokines[J]. Chin J Phys Med Rehabil, 2006, 28(5):323-324.
|
[20] |
Fu Y J, Cheng Y X, Wu Y T. Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools[J]. Virologica Sinica, 2020, 35(3):266-271.
doi: 10.1007/s12250-020-00207-4
|
[21] |
中国康复医学会. 基于新型冠状病毒肺炎的呼吸道感染性疾病疫情期间康复诊疗专家共识[J]. 中华物理医学与康复杂志, 2020, 42(2):97-101.
|
|
Chinese Association of Rehabilitation Medicine. Expert consensus on rehabilitation practice during outbreaks of the novel coronavirus pneumonia and other infectious respiratory diseases[J]. Chin J Phys Med Rehabil, 2020, 42(2):97-101.
|
[22] |
喻鹏铭, 何成奇, 高强, 等. 新型冠状病毒肺炎患者全周期物理治疗操作规范和建议[J]. 中华物理医学与康复杂志, 2020, 42(2):102-104.
|
|
Yu P M, He C Q, Gao Q, et al. Guidelines and recommendations for full cycle physical therapy for COVID-19 patients[J]. Chin J Phys Med Rehabil, 2020, 42(2):102-104.
|
[23] |
喻鹏铭, Jones A Y M, Laakso E L. 应用超短波疗法治疗COVID-19患者需考虑的风险[J]. 康复学报, 2020, 30(2):4-7.
|
|
Yu P M, Jones A Y M, Laakso E L. Considerations for use of ultrashort wave therapy in management of COVID-19 patients[J]. Acta Rehabil, 2020, 30(2):4-7.
|
[24] |
姜俊良, 王丽琼, 宋康平, 等. 超短波透热疗法治疗新型冠状病毒肺炎的思考[J]. 华西医学, 2020, 35(5):534-537.
|
|
Jiang J L, Wang L Q, Song K P, et al. Thoughts on ultrashort wave diathermy therapy for COVID-19[J]. West Chin Med, 2020, 35(5):534-537.
|
[25] |
Wang Q, Zheng X, Cheng Y, et al. Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na, K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury[J]. J Immunol (Baltimore), 2014, 192(8):3765-3777.
|
[26] |
Liu D, Zheng B X, Zhang S H, et al. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats[J]. Crit Care Med, 2005, 33(10):2309-2316.
doi: 10.1097/01.CCM.0000183161.81503.7D
|
[27] |
Mikawa K, Nishina K, Takao Y, et al. ONO-1714, a nitric oxide synthase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits[J]. Anesth Analg, 2003, 97(6):1751-1755.
doi: 10.1213/01.ANE.0000086896.90343.13
|
[28] |
Komiya K, Akaba T, Kozaki Y, et al. A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema[J]. Crit Care, 2017, 21(1):228.
doi: 10.1186/s13054-017-1809-8
|
[29] |
Dias-Freitas F, Metelo-Coimbra C, Roncon-Albuquerque R. Molecular mechanisms underlying hyperoxia acute lung injury[J]. Respir Med, 2016, 119:23-28.
doi: S0954-6111(16)30198-6
pmid: 27692143
|
[30] |
Mokra D, Mikolka P, Kosutova P, et al. Corticosteroids in acute lung injury: the dilemma continues[J]. Int J Mol Sci, 2019, 20(19):4765.
doi: 10.3390/ijms20194765
|
[31] |
Gill S E, Yamashita C M. Lung remodeling associated with recovery from acute lung injury[J]. Cell Tissue Res, 2017, 367(3):495-509.
doi: 10.1007/s00441-016-2521-8
|
[32] |
Chen B Z, Xia R. Pro-inflammatory effects after platelet transfusion: a review[J]. Vox Sanguinis, 2020, 115(5):349-357.
doi: 10.1111/vox.v115.5
|
[33] |
卞向荣, 胡恒, 魏玮. 超短波联合药物治疗小儿肺炎的临床效果[J]. 检验医学与临床, 2017, 14(14):2007-2008.
|
|
Bian X R, Hu H, Wei W, et al. Clinical effect of ultrashort wave combined with drugs in treatment of children with pneumonia[J]. Lab Med Clin, 2017, 14(14):2007-2008.
|
[34] |
An J, Park S H, Ko I G, et al. Polydeoxyribonucleotide ameliorates lipopolysaccharide-induced lung injury by inhibiting apoptotic cell death in rats[J]. Int J Mol Sci, 2017, 18(9):1847.
doi: 10.3390/ijms18091847
|
[35] |
Xie K, Yu Y, Huang Y, et al. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis[J]. Shock, 2012, 37(5):548-555.
doi: 10.1097/SHK.0b013e31824ddc81
|
[36] |
Chambers E D, White A, Vang A, et al. Blockade of equilibrative nucleoside transporter 1/2 protects against Pseudomonas aeruginosa-induced acute lung injury and NLRP3 inflammasome activation[J]. FASEB J, 2020, 34(1):1516-1531.
doi: 10.1096/fj.201902286R
pmid: 31914698
|
[37] |
Wang X, Deng R, Dong J, et al. Eriodictyol ameliorates lipopolysaccharide‐induced acute lung injury by suppressing the inflammatory COX-2/NLRP3/NF-κB pathway in mice[J]. J Biochem Mol Toxicol, 2020, 34(3):e22434.
|
[38] |
Chen H I. Acute lung injury and acute respiratory distress syndrome:experimental and clinical investigations[J]. J GeriatrCardiol, 2011, 8(1):44-54.
|
[39] |
Li D, Ren W, Jiang Z, et al. Regulation of the NLRP3 inflammasome and macrophage pyroptosis by the p38 MAPK signaling pathway in a mouse model of acute lung injury [J]. Mol Med Rep, Jiang, 18(1):4399-4409.
|
[40] |
Grailer J J, Canning B A, Kalbitz M, et al. Critical role for the NLRP3 inflammasome during acute lung injury[J]. J Immunol, 2014, 192(12):5974-5983.
doi: 10.4049/jimmunol.1400368
|
[41] |
He Y, Hara H, Nunez G. Mechanism and regulation of NLRP3 inflammasome activation[J]. Trends Biochem Sci, 2016, 41(12):1012-1021.
doi: 10.1016/j.tibs.2016.09.002
|